{"id":"https://openalex.org/W4306353000","doi":"https://doi.org/10.1038/s41467-022-33867-9","title":"The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial","display_name":"The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial","publication_year":2022,"publication_date":"2022-10-16","ids":{"openalex":"https://openalex.org/W4306353000","doi":"https://doi.org/10.1038/s41467-022-33867-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/36244997","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9573864"},"language":"en","primary_location":{"id":"doi:10.1038/s41467-022-33867-9","doi":"https://doi.org/10.1038/s41467-022-33867-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-33867-9","pdf_url":"https://www.nature.com/articles/s41467-022-33867-9.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41467-022-33867-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070607809","display_name":"Ravi R. Retnakaran","orcid":"https://orcid.org/0000-0003-1989-027X","observed_orcids":["https://orcid.org/0000-0003-1989-027X"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Ravi Retnakaran","raw_affiliation_strings":["Division of Endocrinology, University of Toronto, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca","Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca","Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca","Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":"https://orcid.org/0000-0003-1989-027X","affiliations":[{"raw_affiliation_string":"Division of Endocrinology, University of Toronto, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca","institution_ids":["https://openalex.org/I1291836623"]},{"raw_affiliation_string":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I210557978"]},{"raw_affiliation_string":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110100157","display_name":"Chang Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chang Ye","raw_affiliation_strings":["Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080976453","display_name":"Alexandra Emery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alexandra Emery","raw_affiliation_strings":["Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026062713","display_name":"Caroline Kaercher Kramer","orcid":"https://orcid.org/0000-0003-1064-0100","observed_orcids":["https://orcid.org/0000-0003-1064-0100"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Caroline K. Kramer","raw_affiliation_strings":["Division of Endocrinology, University of Toronto, Toronto, Canada","Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]},{"raw_affiliation_string":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I210557978"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090437675","display_name":"Bernard Zinman","orcid":"https://orcid.org/0000-0002-0041-1876","observed_orcids":["https://orcid.org/0000-0002-0041-1876"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Bernard Zinman","raw_affiliation_strings":["Division of Endocrinology, University of Toronto, Toronto, Canada","Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]},{"raw_affiliation_string":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I210557978"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5070607809"],"corresponding_institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I185261750","https://openalex.org/I210557978"],"apc_list":{"value":5890,"currency":"USD","value_usd":5890},"apc_paid":{"value":5890,"currency":"USD","value_usd":5890},"fwci":2.4905,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.90011864,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"13","issue":"1","first_page":"6109","last_page":"6109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8370000123977661},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.734000027179718},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":0.7630000114440918},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8560000061988831},{"id":"https://openalex.org/keywords/early-type-2-diabetes","display_name":"early type 2 diabetes","score":0.9369999766349792},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.9430000185966492},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7419999837875366},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.5490000247955322},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6690000295639038},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7319999933242798},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.38100001215934753},{"id":"https://openalex.org/keywords/insulin-initiation","display_name":"insulin initiation","score":0.3269999921321869},{"id":"https://openalex.org/keywords/washout-period","display_name":"washout period","score":0.48899999260902405},{"id":"https://openalex.org/keywords/oral-glucose-tolerance","display_name":"oral glucose tolerance","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9511162042617798},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8406099081039429},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.7438732385635376},{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.6898369789123535},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.668785810470581},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6586651802062988},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5829800963401794},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.5293919444084167},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5083333849906921},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4876948297023773},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4795669913291931},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.45598673820495605},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.4407981038093567},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.41949930787086487},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.39442166686058044},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.29977095127105713},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08994755148887634},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061268","descriptor_name":"Insulin Lispro","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/s41467-022-33867-9","doi":"https://doi.org/10.1038/s41467-022-33867-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-33867-9","pdf_url":"https://www.nature.com/articles/s41467-022-33867-9.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9573864","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9573864","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nat Commun","raw_type":"Text"},{"id":"pmid:36244997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36244997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature communications","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33867-9","doi":null,"is_oa":false,"landing_page_url":"https://www.nature.com/articles/s41467-022-33867-9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:7dfbcc22d4e74f62a30ad39bc6fd1bfb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7dfbcc22d4e74f62a30ad39bc6fd1bfb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41467-022-33867-9","doi":"https://doi.org/10.1038/s41467-022-33867-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-33867-9","pdf_url":"https://www.nature.com/articles/s41467-022-33867-9.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G8167780368","display_name":"Exenatide and Insulin Glargine Combination Therapy for the Preservation of Pancreatic Beta-cell Function in Early Type 2 Diabetes: A Randomized Controlled Trial","funder_award_id":"136938_1","funder_id":"https://openalex.org/F4320334506","funder_display_name":"Canadian Institutes of Health Research"},{"id":"https://openalex.org/G8341563619","display_name":null,"funder_award_id":"MOP 136938","funder_id":"https://openalex.org/F4320319880","funder_display_name":"Government of Canada"}],"funders":[{"id":"https://openalex.org/F4320319880","display_name":"Government of Canada","ror":"https://ror.org/010q4q527"},{"id":"https://openalex.org/F4320322015","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087"},{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"},{"id":"https://openalex.org/F4320334604","display_name":"Banting and Best Diabetes Centre, University of Toronto","ror":"https://ror.org/03dbr7087"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4306353000.pdf","grobid_xml":"https://content.openalex.org/works/W4306353000.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1964049889","https://openalex.org/W1966748421","https://openalex.org/W1975663485","https://openalex.org/W1977102586","https://openalex.org/W1984845045","https://openalex.org/W2002757015","https://openalex.org/W2023300718","https://openalex.org/W2029228033","https://openalex.org/W2042200044","https://openalex.org/W2061747541","https://openalex.org/W2069942402","https://openalex.org/W2079529562","https://openalex.org/W2102076191","https://openalex.org/W2105575861","https://openalex.org/W2106758571","https://openalex.org/W2108628281","https://openalex.org/W2119878811","https://openalex.org/W2122643907","https://openalex.org/W2133795831","https://openalex.org/W2134599810","https://openalex.org/W2148798434","https://openalex.org/W2160234571","https://openalex.org/W2164364203","https://openalex.org/W2403039904","https://openalex.org/W2601745204","https://openalex.org/W2606332904","https://openalex.org/W2606513490","https://openalex.org/W2607031541","https://openalex.org/W2894993577","https://openalex.org/W2940507050","https://openalex.org/W3055103903","https://openalex.org/W3093042356","https://openalex.org/W3153606850","https://openalex.org/W3157339478","https://openalex.org/W3196921676","https://openalex.org/W4241784903"],"related_works":["https://openalex.org/W7164867437","https://openalex.org/W4323656511","https://openalex.org/W4382363273","https://openalex.org/W2148798434","https://openalex.org/W7075713001","https://openalex.org/W4381337438","https://openalex.org/W2616718645","https://openalex.org/W7074196286","https://openalex.org/W2035917448","https://openalex.org/W2106758571"],"abstract_inverted_index":{"Combining":[0],"a":[1],"glucagon-like":[2],"peptide-1":[3],"receptor":[4],"agonist":[5],"(GLP1-RA)":[6],"with":[7,77,91],"basal":[8,49,266],"insulin":[9,27,50,93,267],"is":[10],"an":[11,69],"emerging":[12],"option":[13],"when":[14],"initiating":[15],"injectable":[16],"therapy":[17,28],"in":[18,37,51,207,268],"longstanding":[19],"type":[20],"2":[21],"diabetes":[22,283],"(T2DM).":[23],"Recognizing":[24],"that":[25,42],"short-term":[26],"can":[29],"improve":[30],"beta-cell":[31,161,276],"function":[32,162,277],"and":[33,144,156,167,212],"induce":[34],"glycemic":[35,168,288],"remission":[36,245],"early":[38,52,269],"T2DM,":[39,132],"we":[40],"hypothesized":[41],"adding":[43,263],"the":[44,56,173,182,237,279],"short-acting":[45],"GLP1-RA":[46],"exenatide":[47,113,264],"to":[48,88,265,281],"T2DM":[53,82,270],"may":[54],"enhance":[55,274],"achievability":[57],"of":[58,81,125,131,137,160,244],"these":[59],"outcomes.":[60],"In":[61,261],"this":[62],"completed,":[63],"20-week,":[64],"open-label,":[65],"parallel-arm":[66],"trial":[67],"at":[68,152,201],"academic":[70],"hospital,":[71],"103":[72],"individuals":[73],"aged":[74],"30-80":[75],"years":[76,79,130],"<7":[78],"duration":[80],"were":[83,256],"randomized":[84],"(by":[85],"computer-generated":[86],"sequence)":[87],"8-weeks":[89,155,202],"treatment":[90],"(i)":[92],"glargine":[94,100,110],"(Glar;":[95],"n":[96,105,115],"=":[97,106,116,197,221,253],"33),":[98],"(ii)":[99],"+":[101,111],"thrice-daily":[102],"lispro":[103],"(Glar/Lispro;":[104],"35),":[107,117],"or":[108,278],"(iii)":[109],"twice-daily":[112],"(Glar/Exenatide;":[114],"followed":[118,209],"by":[119,210],"12-weeks":[120,224],"washout.":[121],"The":[122],"analyzed":[123],"population":[124],"102":[126],"participants":[127],"(median":[128],"3.5":[129],"A1c":[133,200,229],"6.6%":[134],"\u00b10.7%)":[135],"consisted":[136],"33":[138],"on":[139,142,146],"Glar,":[140],"35":[141],"Glar/Lispro":[143,188,211,248],"34":[145],"Glar/Exenatide.":[147],"Oral":[148],"glucose":[149],"tolerance":[150],"tests":[151],"baseline,":[153],"4-weeks,":[154],"20-weeks":[157],"enabled":[158],"assessment":[159],"(Insulin":[163],"Secretion-Sensitivity":[164],"Index-2":[165],"(ISSI-2))":[166],"control.":[169],"Mean":[170],"ISSI-2":[171,232],"over":[172],"8-week":[174],"intervention":[175],"(primary":[176],"outcome)":[177,204,242],"did":[178,240],"not":[179,272],"differ":[180],"across":[181],"groups":[183],"(Glar/Exenatide":[184,246],"237":[185],"\u00b1":[186,190,194],"11;":[187,191,195],"208":[189],"Glar":[192,213,250],"223":[193],"p":[196,220,252],"0.19).":[198],"Baseline-adjusted":[199],"(secondary":[203,233],"was":[205],"lowest":[206],"Glar/Exenatide":[208],"(mean":[214],"5.9%":[215],"vs":[216,218],"6.0%":[217],"6.2%;":[219],"0.0007).":[222],"After":[223],"washout,":[225],"however,":[226],"neither":[227],"baseline-adjusted":[228,231],"nor":[230,239],"outcomes)":[234],"differed":[235],"between":[236],"groups,":[238],"(additional":[241],"rates":[243],"26.7%,":[247],"43.8%,":[249],"32.1%;":[251],"0.35).":[254],"There":[255],"no":[257],"severe":[258],"hypoglycemia":[259],"episodes.":[260],"conclusion,":[262],"does":[271],"further":[273],"underlying":[275],"capacity":[280],"achieve":[282],"remission,":[284],"despite":[285],"yielding":[286],"on-treatment":[287],"benefit.":[289]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-10-16T00:00:00"}